Robert Foreman has notable professional experience on healthcare, pharmaceuticals, copyright, patent & trademark, medicare & medicaid, and tax issues. Robert currently works at FOREMAN INTL with 1 active client. Robert has represented 7 total clients and has previously worked for FOREMAN INTL and Brown Rudnick LLP . Robert held the following government positions: The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001), Centers for Medicare & and Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005).

Practice Areas

Areas of Experience

National Association of Dental Plans - Healthcare
Duration : 3.0 years (2015 - 2017) active
Revenue : $2,500.00 (monthly) - $177,500.00 (total)
- Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit.

ADVANCED MEDICAL TECHNOLOGY ASSN
Duration : 1.0 years (2006 - 2006) inactive
Revenue : $3,333.00 (monthly) - $60,000.00 (total)
- Medicare and Medicaid Issues

Apotex Corporation
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $16,667.00 (monthly) - $150,000.00 (total)
- H.R.6 - 21st Century Cures Act; ; H.R.2841 - FAST Generics Act of 2015; Implementation of the Biologics Price Competition and Innovation Act (BPCIA)

Hospira, Inc. - Device and drug manufacturer
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $16,667.00 (monthly) - $150,000.00 (total)
- Implementation of the Biologics Price Competition and Innovation Act (BPCIA)

Amneal Pharmaceuticals - General Drug Manufacturer
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $13,333.00 (monthly) - $120,000.00 (total)
- H.R.2841 - FAST Generics Act of 2015
Apotex Corporation
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $16,667.00 (monthly) - $150,000.00 (total)
- Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)

Hospira, Inc. - Device and drug manufacturer
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $16,667.00 (monthly) - $150,000.00 (total)
- Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)

Amneal Pharmaceuticals - General Drug Manufacturer
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $13,333.00 (monthly) - $120,000.00 (total)
- Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
National Association of Dental Plans - Healthcare
Duration : 3.0 years (2015 - 2017) active
Revenue : $2,500.00 (monthly) - $177,500.00 (total)
- Implementation of Affordable Care Act and related regulations related to the pediatric dental benefit; issues and policies related to ensuring tax incentives for emplpoyers and individuals to purchase dental coverage; issues and policies related to preserving Medicaid dental coverage; issues and policies related to the ensuring a competitive market for dental benefits and allowing purchase of dental benefits as part of a medical policy or on a standalone basis; issues and policies related to ...

Miraca Life Sciences - Healthcare
Duration : 0.5 years (2015 - 2015) inactive
Revenue : $13,333.00 (monthly) - $80,000.00 (total)
- Proposals related to anatomic pathology and the in-office ancillary services exception to the Ethics in Patient Referrals Act.

Roche Diagnostics Corporation - Healthcare/Medical
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $16,667.00 (monthly) - $150,000.00 (total)
- Policies related to diagnostic laboratory testing; H.R. 771 Protecting Access to Diabetes Supplies; S. 1101 Medical Electronic Data Technology Enhancement for consumers Health Act; H.R. 6 "21st Century Cures Act".
Apotex Corporation
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $16,667.00 (monthly) - $150,000.00 (total)
- S. 1137-Protecting American Talent and Entrepreneurship Act of 2015

Hospira, Inc. - Device and drug manufacturer
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $16,667.00 (monthly) - $150,000.00 (total)
- S. 1137-Protecting American Talent and Entrepreneurship Act of 2015

Amneal Pharmaceuticals - General Drug Manufacturer
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $13,333.00 (monthly) - $120,000.00 (total)
- S. 1137-Protecting American Talent and Entrepreneurship Act of 2015

TAX

National Association of Dental Plans - Healthcare
Duration : 3.0 years (2015 - 2017) active
Revenue : $2,500.00 (monthly) - $177,500.00 (total)
- Calculation of the advanced premium tax credit as related to the pediatric dental benefit.
Amneal Pharmaceuticals - General Drug Manufacturer
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $13,333.00 (monthly) - $120,000.00 (total)
- Issues relating to abuse deterrent drug development
Hospira, Inc. - Device and drug manufacturer
Duration : 0.7 years (2015 - 2015) inactive
Revenue : $16,667.00 (monthly) - $150,000.00 (total)
- Issues relating to medical product cybersecurity

Top Expertise

  • HEALTHCARE
  • PHARMACEUTICALS
  • COPYRIGHT
  • PATENT & TRADEMARK
  • MEDICARE & MEDICAID
  • TAX

Clients

Current

  • National Association of Dental Plans

Past

  • ADVANCED MEDICAL TECHNOLOGY ASSN
  • Amneal Pharmaceuticals
  • Apotex Corporation
  • Hospira, Inc.
  • Miraca Life Sciences
  • Roche Diagnostics Corporation